Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Prescription Issuance: If eligible, a prescription is written specifically for the Canadian market
PMCID: PMC11707257
Designed based on an in-depth understanding of incretin biology, tirzepatide can simultaneously activate GLP-1 and GIP receptors, thereby exerting synergistic effects that translate into superior outcomes in glycemic control, body weight management, and pancreatic -cell function preservation (19, 20)
Missing weeks of medication can set back your progress and potentially trigger weight regain
Visible weight loss typically begins within 24 weeks
Lipid changes may persist longer if weight loss is maintained
US$ 27.51
US$ 25.57
US$ 25.24
US$ 20.32
US$ 22.59
US$ 22.46
:max_bytes(150000):strip_icc():focal(749x0:751x2)/tout-Mans-Gallbladder-Gets-Infected-from-GLP-1-042726-a19822b08d324fe6a148a91dcdcb5ae9.jpg)
